Table 4 Anti-HBs status among studied patients.
Anti HBs | Test | P | ||||
|---|---|---|---|---|---|---|
Positive (n = 18) | Negative (n = 137) | |||||
Age (years) | t Test | |||||
X- ± SD | 43.4 ± 6.5 | 41.6 ± 9.5 | 0.79 | 0.43 | ||
Range | 29-53 | 19-59 | ||||
Sex | No. | % | No. | % | X 2 | |
M | 16 | 88.9 | 109 | 79.6 | 0.39 | 0.53 |
F | 2 | 11.1 | 28 | 20.4 | ||
Activity | No. | % | No. | % | X 2 | |
1 | 7 | 38.9 | 45 | 32.8 | ||
2 | 11 | 61.1 | 60 | 43.8 | 5.42 | 0.06 |
3 | 0 | 0.0 | 32 | 23.4 | ||
Fibrosis | No. | % | No. | % | X 2 | |
1 | 4 | 22.2 | 50 | 36.5 | ||
2 | 12 | 66.7 | 49 | 35.8 | 6.6 | 0.08 |
3 | 2 | 11.1 | 34 | 24.8 | ||
4 | 0 | 0.0 | 4 | 2.9 | ||
Basal HCV Viral Load (IU × 105) | t Test | |||||
X- ± SD | 2.3 ± 3.9 | 4.1 ± 5.9 | 1.24 | 0.21 | ||
Range | 0.006-12.9 | 0.001-22.3 | ||||
Basal ALT (× ULN) | No. | % | No. | % | X 2 | |
≤ 2 | 16 | 88.9 | 102 | 74.5 | 1.12 | 0.29 |
> 2 | 2 | 11.1 | 35 | 25.5 | ||
Basal AST (× ULN) | No. | % | No. | % | X 2 | |
≤ 2 | 18 | 100 | 108 | 78.8 | 4.69 | 0.03 |
> 2 | 0.0 | 0.0 | 29 | 21.2 | ||
HBV DNA | No. | % | No. | % | X 2 | |
Positive | 0 | 0.0 | 6 | 4.4 | 0.82 | 0.36 |
Negative | 18 | 100 | 131 | 95.6 | ||
Response Rate | No. | % | No. | % | X 2 | |
Responder | 10 | 55.6 | 60 | 43.8 | 0.89 | 0.34 |
Non-responder | 8 | 44.4 | 77 | 56.2 | ||
Anti-HBc | No. | % | No. | % | X 2 | |
Positive | 4 | 22.2 | 14 | 10.2 | 1.22 | 0.26 |
Negative | 14 | 77.8 | 123 | 89.8 | ||